AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Digestive Health: These probiotics can help maintain a healthy balance of gut microbiota, which is crucial for digestion and nutrient absorption. They may alleviate symptoms of gastrointestinal disorders such as irritable bowel syndrome (IBS), diarrhea, constipation, and inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis.
Immune System Support: Lactobacillus delbrueckii subsp. bulgaricus, Bifidobacterium bifidum, and Enterococcus faecium may enhance the body's immune response by promoting the production of anti-inflammatory cytokines and strengthening the gut barrier function. This can help reduce the risk of infections and allergies and may support overall immune system function.
Vaginal Health: These probiotics may also contribute to maintaining a healthy vaginal microbiota by preventing the overgrowth of harmful bacteria and yeast. They can help prevent or treat vaginal infections such as bacterial vaginosis and yeast infections, as well as urinary tract infections (UTIs) by maintaining an acidic pH and producing antimicrobial substances.
Nutrient Synthesis: Bifidobacterium bifidum, in particular, is known for its ability to synthesize vitamins such as vitamin B12 and vitamin K, which are important for various physiological functions including blood clotting and nerve function.
Lactose Intolerance: Lactobacillus delbrueckii subsp. bulgaricus is commonly used in the fermentation of dairy products such as yogurt and may help improve lactose digestion in individuals with lactose intolerance by producing lactase enzyme.
Antimicrobial Activity: Some strains of Enterococcus faecium produce antimicrobial substances that can inhibit the growth of pathogenic bacteria, thereby reducing the risk of bacterial infections in the gut and other parts of the body.
Mood and Mental Health: Emerging research suggests a potential link between gut microbiota and mental health. Probiotics like Bifidobacterium bifidum may exert beneficial effects on mood and cognitive function by modulating neurotransmitter production and reducing inflammation in the gut-brain axis.
lactobacillus delbrueckii bulgaricus,bifidobacterium bifidum,enterococcus faecium,candida pintolopesii,aspergillus oryzae
Rank | Probiotic | Impact |
---|---|---|
genus | Bacillus | Reduces |
genus | Bifidobacterium | Increases |
genus | Pediococcus | Increases |
order | Micrococcales | Increases |
species | Akkermansia muciniphila | Increases |
species | Bacillus aeolius | Reduces |
species | Bacillus horti | Reduces |
species | Bacillus infernus | Reduces |
species | Bacillus licheniformis | Reduces |
species | Bacillus pumilus | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
17 | 0 | Lactobacillus | genus | Increases |
14 | 1 | Bifidobacterium | genus | Increases |
14 | 1 | Escherichia coli | species | Decreases |
8 | 1 | Bacillota | phylum | Increases |
8 | 0 | Pseudomonadota | phylum | Decreases |
7 | 12 | Escherichia | genus | Decreases |
7 | 0 | Bacteroides | genus | Increases |
7 | 0 | Bacteroidota | phylum | Decreases |
6 | 9 | Lachnospiraceae | family | Increases |
6 | 1 | Bacteroidia | class | Decreases |
6 | 0 | Akkermansia | genus | Increases |
5 | 6 | Oscillospiraceae | family | Decreases |
5 | 3 | Roseburia | genus | Increases |
5 | 3 | Blautia | genus | Increases |
5 | 1 | Shigella | genus | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.4 | 0.1 | 3 |
Acne | 3.7 | 1.2 | 2.08 |
Addison's Disease (hypocortisolism) | 0.5 | 0.5 | |
ADHD | 4.5 | 4.9 | -0.09 |
Age-Related Macular Degeneration and Glaucoma | 0.4 | 0.8 | -1 |
Allergic Rhinitis (Hay Fever) | 4.4 | 3.5 | 0.26 |
Allergies | 9.6 | 7.1 | 0.35 |
Allergy to milk products | 3.5 | 3.1 | 0.13 |
Alopecia (Hair Loss) | 1.8 | 2.5 | -0.39 |
Alzheimer's disease | 12.9 | 13.8 | -0.07 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. β Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA β Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. β Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. β Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]